Jacqueline E. Mann

470 total citations
20 papers, 297 citations indexed

About

Jacqueline E. Mann is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jacqueline E. Mann has authored 20 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Jacqueline E. Mann's work include Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (3 papers). Jacqueline E. Mann is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (3 papers). Jacqueline E. Mann collaborates with scholars based in United States and Czechia. Jacqueline E. Mann's co-authors include J. Chad Brenner, Matthew E. Spector, S. Hunt, William E. Rainey, Valentina Crudo, Gary D. Hammer, Christopher R. LaPensee, Andrew C. Birkeland, Mark E. Prince and Jonathan B. McHugh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Jacqueline E. Mann

17 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacqueline E. Mann United States 9 126 123 93 83 68 20 297
Simona Tortorella Italy 8 185 1.5× 107 0.9× 61 0.7× 57 0.7× 37 0.5× 12 334
Zu‐Lu Ye China 11 114 0.9× 112 0.9× 85 0.9× 28 0.3× 28 0.4× 24 277
Aizhong Shao China 11 253 2.0× 69 0.6× 182 2.0× 53 0.6× 85 1.3× 23 408
Astrid De Meulenaere Belgium 10 49 0.4× 261 2.1× 40 0.4× 107 1.3× 65 1.0× 16 329
Yang Mh Taiwan 8 169 1.3× 92 0.7× 67 0.7× 63 0.8× 23 0.3× 12 331
Agustín Herrero Zapatero Spain 5 161 1.3× 94 0.8× 62 0.7× 31 0.4× 31 0.5× 11 261
Paul‐Yang Lin Taiwan 8 128 1.0× 130 1.1× 53 0.6× 114 1.4× 83 1.2× 8 335
Brian C. Willis United States 7 79 0.6× 162 1.3× 52 0.6× 54 0.7× 34 0.5× 9 305
Xiao Zhao China 9 84 0.7× 202 1.6× 41 0.4× 67 0.8× 32 0.5× 29 323
Shaochuan Liu China 9 106 0.8× 237 1.9× 54 0.6× 121 1.5× 23 0.3× 15 362

Countries citing papers authored by Jacqueline E. Mann

Since Specialization
Citations

This map shows the geographic impact of Jacqueline E. Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline E. Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline E. Mann more than expected).

Fields of papers citing papers by Jacqueline E. Mann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline E. Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline E. Mann. The network helps show where Jacqueline E. Mann may publish in the future.

Co-authorship network of co-authors of Jacqueline E. Mann

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline E. Mann. A scholar is included among the top collaborators of Jacqueline E. Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline E. Mann. Jacqueline E. Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perdigoto, Ana Luisa, Jacqueline E. Mann, Martha Torres, et al.. (2025). Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes. Journal for ImmunoTherapy of Cancer. 13(9). e012358–e012358.
2.
Schoenfeld, David A., Dijana Djureinovic, David Su, et al.. (2024). Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti–CTLA-4 in renal cell carcinoma. JCI Insight. 10(1). 6 indexed citations
3.
Mann, Jacqueline E., David Su, Adebowale Adeniran, et al.. (2024). GP100 expression is variable in intensity in melanoma. Cancer Immunology Immunotherapy. 73(10). 191–191. 3 indexed citations
4.
Mann, Jacqueline E., Joshua D. Smith, Aditi Kulkarni, et al.. (2023). Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma. Oral Oncology. 146. 106562–106562. 9 indexed citations
5.
Mann, Jacqueline E., Liliana E. Lucca, Ross D. Merkin, et al.. (2023). ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis. Journal for ImmunoTherapy of Cancer. 11(8). e007358–e007358. 6 indexed citations
6.
Schoenfeld, David A., Dijana Djureinovic, Lin Zhang, et al.. (2023). 1070 ‘Decoy-resistant’ IL-18 in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma. SHILAP Revista de lepidopterología. A1177–A1179. 1 indexed citations
7.
Mann, Jacqueline E., Liliana E. Lucca, Matthew Austin, et al.. (2023). Abstract 2268: Single cell RNA sequencing defines dynamic immune cell subsets in serial colon and peripheral blood samples in a patient with checkpoint inhibitor-induced colitis. Cancer Research. 83(7_Supplement). 2268–2268.
8.
Merkin, Ross D., David A. Schoenfeld, Dijana Djureinovic, et al.. (2023). Peripheral blood immune cell and cytokine profiling of patients receiving corticosteroids for immune checkpoint inhibitor-related adverse events: Steroid dose and duration.. Journal of Clinical Oncology. 41(16_suppl). e14694–e14694.
9.
Mann, Jacqueline E., et al.. (2021). Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in HNSCC. Cancers. 13(19). 4782–4782. 4 indexed citations
10.
Michmerhuizen, Nicole L., John H. Owen, Molly E. Heft Neal, et al.. (2020). Rationale for the advancement of PI3K pathway inhibitors for personalized chordoma therapy. Journal of Neuro-Oncology. 147(1). 25–35. 13 indexed citations
11.
Neal, Molly E. Heft, Catherine T. Haring, Jacqueline E. Mann, et al.. (2019). Novel immunotherapeutic approaches in head and neck cancer. Journal of Cancer Metastasis and Treatment. 2019. 7 indexed citations
12.
Mann, Jacqueline E., Aditi Kulkarni, Andrew C. Birkeland, et al.. (2019). The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel. Head & Neck. 41(9). 3114–3124. 24 indexed citations
13.
Ludwig, Megan, Aditi Kulkarni, Andrew C. Birkeland, et al.. (2018). The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines. Oral Oncology. 87. 144–151. 24 indexed citations
14.
Mann, Jacqueline E., Joshua D. Smith, Andrew C. Birkeland, et al.. (2018). Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma. Cancer Immunology Immunotherapy. 68(2). 213–220. 34 indexed citations
15.
Schmoker, Anna M., et al.. (2018). Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. Proteomes. 6(4). 37–37. 8 indexed citations
16.
Hoesli, Rebecca C., Andrew C. Birkeland, Andrew J. Rosko, et al.. (2017). Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma. Oral Oncology. 77. 83–89. 50 indexed citations
17.
Birkeland, Andrew C., Megan Ludwig, Jacqueline E. Mann, et al.. (2017). Abstract 814: NOTCH1 regulates head and neck cancer cell growth and invasion. Cancer Research. 77(13_Supplement). 814–814. 1 indexed citations
18.
Mann, Jacqueline E., Megan Ludwig, Aditi Kulkarni, et al.. (2017). Abstract 28: Identifying mechanisms of PD-L1 regulation in HNSCC. Clinical Cancer Research. 23(23_Supplement). 28–28. 1 indexed citations
19.
LaPensee, Christopher R., Jacqueline E. Mann, William E. Rainey, et al.. (2016). ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs. Endocrinology. 157(5). 1775–1788. 71 indexed citations
20.
Birkeland, Andrew C., Megan Yanik, Susan K. Foltin, et al.. (2016). Identification of TargetableERBB2Aberrations in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery. 142(6). 559–559. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Tortorella Breakdown of academic impact, for papers by Zu‐Lu Ye Breakdown of academic impact, for papers by Aizhong Shao Breakdown of academic impact, for papers by Astrid De Meulenaere Breakdown of academic impact, for papers by Yang Mh Breakdown of academic impact, for papers by Agustín Herrero Zapatero Breakdown of academic impact, for papers by Paul‐Yang Lin Breakdown of academic impact, for papers by Brian C. Willis Breakdown of academic impact, for papers by Xiao Zhao Breakdown of academic impact, for papers by Shaochuan Liu
Rankless by CCL
2026